title: Drug content effects on the dispersion performance of adhesive mixtures for inhalation.
abstract: The drug content in adhesive mixtures for inhalation is known to influence their dispersion performance, but the direction and magnitude of this influence depends on other variables. In the past decades several mechanisms have been postulated to explain this finding and a number of possible interacting variables have been identified. Still, the role of drug content in the formulation of adhesive mixtures for inhalation, which includes its significance as an interacting variable to other parameters, is poorly understood. Therefore, the results from a series of drug detachment experiments are presented in which the effect of drug content and its dependence on flow rate, the mixing time and the type of drug is studied. Furthermore, it is investigated whether the effect depends on the range within which the drug content is changed. Quantitative and qualitative multiple order interactions are observed between these variables, which may be explained by a shifting balance between three different mechanisms. The results therefore demonstrate that accounting for (multiple order) interactions between variables has to be part of quality by design activities and the rational design of future experiments.
authors: Department of Pharmaceutical Technology and Biopharmacy, University of Groningen, Groningen, The Netherlands. F.Grasmeijer@rug.nl
authors: Floris
authors: F
authors: Grasmeijer
authors: Paul
authors: P
authors: Hagedoorn
authors: Henderik W
authors: HW
authors: Frijlink
authors: Anne H
authors: AH
authors: de Boer
mesh_terms: D000269:Adhesives / Q000737:chemistry*; D000280:Administration, Inhalation; D002626:Chemistry, Pharmaceutical / Q000379:methods*; D004337:Drug Carriers / Q000737:chemistry; D007785:Lactose / Q000737:chemistry; D007834:Lasers; D004364:Pharmaceutical Preparations / Q000008:administration & dosage* / Q000737:chemistry*; D013997:Time Factors
chemical_list: D000269:Adhesives; D004337:Drug Carriers; D004364:Pharmaceutical Preparations; D007785:Lactose
references: Pharm Res. 2004 Dec;21(12):2167-74
references: 15648247
references: Pharm Res. 2008 Feb;25(2):337-48
references: 17952568
references: Int J Pharm. 2005 May 30;296(1-2):26-33
references: 15885452
references: Pharm Res. 2004 Dec;21(12):2158-66
references: 15648246
references: Int J Pharm. 2003 Jul 24;260(2):187-200
references: 12842339
references: Adv Drug Deliv Rev. 2012 Mar 15;64(3):257-74
references: 21565232
references: Int J Pharm. 2005 Apr 27;294(1-2):173-84
references: 15814242
references: Int J Pharm. 2012 Mar 15;424(1-2):44-9
references: 22207163
references: Eur J Pharm Biopharm. 2008 Jun;69(2):496-507
references: 18191553
references: Pharm Res. 2002 Oct;19(10):1524-31
references: 12425471
references: J Pharm Sci. 2006 Jun;95(6):1288-97
references: 16637052
references: Eur J Pharm Biopharm. 2004 May;57(3):495-505
references: 15093599
references: J Pharm Pharmacol. 1987 May;39(5):329-34
references: 2886579
references: Eur J Pharm Biopharm. 2003 Sep;56(2):291-302
references: 12957644
references: J Pharm Pharmacol. 1987 Sep;39(9):673-8
references: 2890731